Fiduciary Trust’s NeoGenomics NEO Stock Holding History

Fiduciary Trust’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$581K	Buy	39,788 +1,733	+5%	+$16.7K	0.01%	554
2026 Q1	$282K	Hold	38,055	–	–	﹤0.01%	753
2025 Q4	$448K	Hold	38,055	–	–	0.01%	594
2025 Q3	$294K	Hold	38,055	–	–	﹤0.01%	716
2025 Q2	$278K	Buy	38,055 +27,941	+276%	+$225K	﹤0.01%	702
2025 Q1	$96K	Buy	+10,114	New	+$126K	﹤0.01%	808

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Fiduciary Trust's NEO Position: Q2 2026 in Review

Fiduciary Trust increased its NeoGenomics (NEO) stake by 4.6% in Q2 2026, buying an estimated $16.7K and bringing the position to 39,788 shares worth $581K. The position accounts for 0.01% of the portfolio, ranked #554.

Fiduciary Trust first reported a position in NEO in Q1 2025 and has held it in 6 quarters since. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Fiduciary Trust held 39,788 shares of NeoGenomics worth $581K as of Q2 2026.
Fiduciary Trust bought 1,733 NeoGenomics shares in Q2 2026, an estimated $16.7K.
NeoGenomics made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #554 holding.
Fiduciary Trust first reported a position in NeoGenomics in Q1 2025 and has held it in 6 quarters since.
267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.